Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy.

[1]  Katherine C. Wu,et al.  Infarct Tissue Heterogeneity by Magnetic Resonance Imaging Identifies Enhanced Cardiac Arrhythmia Susceptibility in Patients With Left Ventricular Dysfunction , 2007, Circulation.

[2]  Dudley J Pennell,et al.  Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. , 2006, Journal of the American College of Cardiology.

[3]  Barry J Maron,et al.  Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interd , 2006, Circulation.

[4]  L. Stevenson,et al.  Characteristics of patients who die with heart failure and a low ejection fraction in the new millennium. , 2006, Journal of cardiac failure.

[5]  Robert G. Weiss,et al.  Magnetic Resonance Assessment of the Substrate for Inducible Ventricular Tachycardia in Nonischemic Cardiomyopathy , 2005, Circulation.

[6]  J. Ornato,et al.  ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult—Summary Article , 2005 .

[7]  Douglas L Mann,et al.  Mechanisms and models in heart failure: the biomechanical model and beyond. , 2005, Circulation.

[8]  Douglas L Packer,et al.  Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. , 2005, The New England journal of medicine.

[9]  Akshay S. Desai,et al.  Implantable Defibrillators for the Prevention of Mortality in Patients With Nonischemic Cardiomyopathy: A Meta-analysis of Randomized Controlled Trials , 2004 .

[10]  A. Khasnis,et al.  Prophylactic Defibrillator Implantation in Patients With Nonischemic Dilated Cardiomyopathy , 2004 .

[11]  A. Moss,et al.  Analysis of mortality events in the Multicenter Automatic Defibrillator Implantation Trial (MADIT-II). , 2004, Journal of the American College of Cardiology.

[12]  Dan W Rettmann,et al.  Accurate and Objective Infarct Sizing by Contrast-enhanced Magnetic Resonance Imaging in a Canine Myocardial Infarction Model , 2022 .

[13]  Dipan J. Shah,et al.  Gadolinium Cardiovascular Magnetic Resonance Predicts Reversible Myocardial Dysfunction and Remodeling in Patients With Heart Failure Undergoing &bgr;-Blocker Therapy , 2003, Circulation.

[14]  C H Lorenz,et al.  Differentiation of Heart Failure Related to Dilated Cardiomyopathy and Coronary Artery Disease Using Gadolinium‐Enhanced Cardiovascular Magnetic Resonance , 2003, Circulation.

[15]  F. Marchlinski,et al.  Characterization of the Electroanatomic Substrate for Monomorphic Ventricular Tachycardia in Patients with Nonischemic Cardiomyopathy , 2002, Pacing and clinical electrophysiology : PACE.

[16]  C. O'connor,et al.  A standardized definition of ischemic cardiomyopathy for use in clinical research. , 2002, Journal of the American College of Cardiology.

[17]  N. de Leeuw,et al.  Histopathologic findings in explanted heart tissue from patients with end-stage idiopathic dilated cardiomyopathy , 2001, Transplant international : official journal of the European Society for Organ Transplantation.

[18]  O. Simonetti,et al.  An improved MR imaging technique for the visualization of myocardial infarction. , 2001, Radiology.

[19]  W. Stevenson,et al.  Mapping and Radiofrequency Catheter Ablation of the Three Types of Sustained Monomorphic Ventricular Tachycardia in Nonischemic Heart Disease , 2000, Journal of cardiovascular electrophysiology.

[20]  ICHAEL,et al.  UNDERLYING CAUSES AND LONG-TERM SURVIVAL IN PATIENTS WITH INITIALLY UNEXPLAINED CARDIOMYOPATHY , 2000 .

[21]  W. Mckenna,et al.  The pathophysiology of advanced heart failure. , 1998, Heart & lung : the journal of critical care.

[22]  W. Mckenna,et al.  The pathophysiology of advanced heart failure. , 1999, American heart journal.

[23]  M. Fishbein,et al.  Characteristics of wave fronts during ventricular fibrillation in human hearts with dilated cardiomyopathy: role of increased fibrosis in the generation of reentry. , 1998, Journal of the American College of Cardiology.

[24]  W. Roberts,et al.  Comparison of clinical and morphologic cardiac findings in patients having cardiac transplantation for ischemic cardiomyopathy, idiopathic dilated cardiomyopathy, and dilated hypertrophic cardiomyopathy. , 1998, The American journal of cardiology.

[25]  C M O'Connor,et al.  Clinical determinants of mortality in patients with angiographically diagnosed ischemic or nonischemic cardiomyopathy. , 1997, Journal of the American College of Cardiology.

[26]  S. Pogwizd,et al.  Mechanisms Underlying Spontaneous and Induced Ventricular Arrhythmias in Patients With Idiopathic Dilated Cardiomyopathy , 1996 .

[27]  E. Sonnenblick,et al.  The cellular basis of dilated cardiomyopathy in humans. , 1995, Journal of molecular and cellular cardiology.

[28]  B. McManus,et al.  Idiopathic dilated cardiomyopathy: analysis of 152 necropsy patients. , 1987, The American journal of cardiology.

[29]  M. Thompson,et al.  Extent of myocardial fibrosis and cellular hypertrophy in dilated cardiomyopathy. , 1986, The American journal of cardiology.